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Abstract
Since 2008, Mainland China has undergone widespread outbreaks of hand, foot, and mouth 
disease (HFMD). In order to determine the characteristics of epidemics and enteroviruses (EV) 
associated with HFMD in Tianjin, in northern China, epidemiological and virological data from 
routine surveillance were collected and analyzed. In Tianjin, a persistent epidemic of HFMD was 
demonstrated during 2008–2013, involving 102,705 mild, 179 severe, and 16 fatal cases. Overall, 
8234 specimens were collected from 7829 HFMD patients for EV detection during 2008–2013. 
Enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16) were the dominant serotypes during 
2008–2012, and they were replaced by CV-A6 as the major causative agent in 2013. Phylogenetic 
analysis based on complete VP1 nucleotide sequences revealed that multiple CV-A6 lineages co-
circulated in Tianjin, which grouped together with strains from China and other countries and split 
into two distinct clusters (clusters 1 and 2). Most Tianjin strains grouped in cluster 1 and were 
closely related to strains from several eastern and southern provinces of China during 2012 and 
2013. Estimates from Bayesian MCMC analysis suggested that multiple lineages had been 
transmitted silently before the outbreaks at an estimated evolutionary rate of 4.10 × 10−3 
substitutions per site per year without a specific distribution of rate variances among lineages. The 
sudden outbreak of CV-A6 in Tianjin during 2013 is attributed to indigenous CV-A6 lineages, 
which were linked to the wide spread of endemic strains around eastern and southern China.
Introduction
Hand, foot, and mouth disease (HFMD) is a common infectious disease caused by human 
enteroviruses (EVs) that usually attacks children. Enterovirus 71 (EV-A71) and 
coxsackievirus A16 (CV-A16) are the major pathogens causing HFMD [1, 3, 11, 12, 22, 
29]. Other EVs, such as CV-A4, CV-A5, CV-A6, CV-A10, and CV-A12, are also often 
associated with HFMD [7, 8, 10, 16, 26, 28, 30]. Notably, circulation of CV-A6 and CV-
A10 has become more active recently, causing several HFMD outbreaks around the world 
since 2008 [7, 8, 13, 15, 16, 21, 27].
In Mainland China, HFMD was classified as a notifiable disease in 2008, and nationwide 
surveillance has been performed since then. Tianjin is one of the four directly controlled 
municipalities, located in northern China. As part of national surveillance, both 
epidemiological and virological surveillance for HFMD have been carried out in Tianjin 
since 2008 and have indicated a persistent HFMD epidemic.
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In this study, epidemiological and virological investigations were performed to characterize 
the epidemics of HFMD in Tianjin during 2008–2013. Analyses based on complete VP1 
nucleotide sequences were performed to determine the evolutionary trajectory of emerging 
CV-A6.
Materials and methods
Collection of epidemiological data
As a notifiable disease in China, demographic and epidemiologic data from HFMD cases are 
collected using a standard case investigation form and reported online to the China 
Information System for Disease Control and Prevention [24, 29]. Epidemiological data in 
this study were retrieved from this national database. In this study, an epidemic season of 
HFMD was defined as a period of ≥2 consecutive weeks when the weekly number of 
reported cases accounted for ≥2.0 % of the cases reported in that year. The epidemic peak is 
the week when the number of weekly reported cases is the highest.
Mild cases of HFMD have good prognosis, without serious complications. In a few patients, 
the central nervous system (CNS) is involved, and these cases are considered severe. For 
clinical classification, we followed Guidelines for Diagnosis and Management of Hand, 
Foot and Mouth Disease (2010) (http://www.moh.gov.cn/publicfiles/business/htmlfiles/
mohyzs/s3586/201004/46884.htm), released by China Ministry of Health.
Specimen collection and processing
Because HFMD is notifiable, as part of routine virological surveillance, specimens were 
routinely collected from clinically diagnosed HFMD cases in Tianjin city within 7 days of 
the onset of illness. From 8 April 2008 to 3 December 2013, a total of 8234 specimens (7631 
stools, 1 CSF, 80 sera, and 522 throat swabs) were collected from 7829 patients for EV 
detection (Fig. 1a). Stool specimens were processed as described previously [17] for 
subsequent viral RNA extraction. Specimens of other types were used directly for viral RNA 
extraction. As a public-health surveillance activity, ethical review was not required.
Viral RNA extraction and detection
Viral RNA was extracted using a QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, 
USA). EV-A71, CV-A16, and pan-EV RNA detection were routinely performed. Previously 
described conventional RT-PCR methods [32] were used during 2008 to 2009, and 
commercial serotype-specific real-time RT-PCR (rRT-PCR) kits were employed beginning 
in 2010 (from 2010 to 2012, Taitaigen, Shenzhen, China; in 2013, Mole, Taizhou, China).
In 2013, additional detection was performed using commercial CV-A6- and CV-A10-
specific rRT-PCR kits (Shuoshi, Taizhou, China) because of the increased number of other 
EV serotypes. rRT-PCR was performed according to the manufacturer’s instructions.
VP1 sequencing of CV-A6
Degenerate primer pairs (486/488 and 040/012/011) were used for amplification of a partial 
VP1 sequence of CV-A6 [18, 19]. Also, the complete VP1-encoding region of CV-A6 was 
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amplified from some of the specimens, using the forward primer 5′-
CTTCGTAGTGCCACCAGATA-3′ (nucleotides 2317–2336; all of the nucleotide positions 
in this study correspond to those of CV-A6/Gdula: AY421764) and the reverse primer 5′-
GTGGCGAGATGTCGGTTTA-3′ (nucleotides 3408–3426). PCR products were purified 
and sequenced as described previously [32]. Sequences were edited and assembled by using 
Sequencher 5.0 software (Gene Codes, Ann Arbor, MI, USA). All of the sequences 
determined (n=73) were deposited in Gen-Bank, with accession numbers KJ774060-
KJ774103 and KJ848296-KJ848324.
Evolutionary analysis of CV-A6
Multiple sequence alignments, estimation of genetic distance, and construction of 
maximum-likelihood (ML) trees were performed using MEGA 5.1 software [6, 23]. Branch 
lengths were estimated using the general time-reversible (GTR) nucleotide substitution 
model [31] and a gamma distribution of rates among sites (Γ4) as estimated by Modeltest 
[20]. A majority-rule consensus tree was obtained after 1,000 pseudo-replicates.
Bayesian Markov chain Monte Carlo (MCMC) methods were used to estimate evolutionary 
characteristics using BEAST v1.8 (http://beast.bio.ed.ac.uk/) with the relaxed clock model 
[5]. Two independent MCMC chains were run for each BEAST analysis (80 million 
generations each) and sampling efficiency was measured using the effective sampling size 
(ESS) function in TRACER v1.5 (http://tree.bio.ed.ac.uk/software/tracer/). Confidence 
intervals for evolutionary estimates were obtained as 95 % high posterior density intervals 
(95 % HPD). Results from the two independent chains were combined into a maximum 




From 1 January 2008 to 31 December 2013, a total of 102,705 HFMD cases were reported 
in Tianjin, including 179 (1.74‰) severe cases with CNS complications and 16 (0.16‰) 
fatal cases (Table 1). Incidence rates ranged from 70.3 to 229.4 cases per 100,000 
individuals. Based on the data from 2010 to 2013, the epidemic season in Tianjin extended 
from as early as week 19 to as late as week 33 (May to August), with an epidemic peak 
around weeks 24 to 27, when the proportion of weekly reported cases relative to annually 
reported cases ranged from 8.6 % to 9.2 % (Fig. 1a). Overall, 73.8 % (75,848/102,705) of all 
cases, 78.8 % (141/179) of severe cases, and 87.5 % (14/16) of fatal cases occurred in the 
epidemic season during 2008 to 2013 (Fig. 1).
Children <6 years old constituted the majority of subjects affected by HFMD, accounting for 
88.2 % (90,558/102,705) of reported cases and all of the fatal cases. Children aged 1–4 years 
showed higher age-specific incidence rates, ranging from 882.9 to 4583.4 cases per 100,000 
per year (Fig. 2). Children aged <1 year showed the highest fatality rate (39 deaths per 
100,000 reported cases).
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During 2008–2013, assays for EV were performed on samples from 7,829 patients (7.6 % of 
reported cases), and 72.8 % were EV positive (Table 2). Virus surveillance in Tianjin 
revealed a serotype change during 2008–2013. During 2009–2012, EV-A71 was the most 
commonly detected serotype, and CV-A16 was the second most commonly detected, except 
in 2011 (Table 2). In 2013, detection of other EVs increased sharply, accounting for 64.7 % 
of all EVs detected (Table 2). CV-A6 was found to have displaced both EV-A71 and CV-
A16 as the dominant serotype in 2013, accounting for 54.3 % (741/1364) of total EVs 
detected (Table 2).
Evolutionary analysis of CV-A6
Analysis of partial VP1 nucleotide sequences (nucleotides 2980–3355) indicated that CV-
A6 strains in this study (n = 73) had 82.5 %–87.6 % nucleotide sequence identity to the CV-
A6 prototype (CV-A6/Gdula, AY421764). In the ML tree (Figure S1), out of 73 CV-A6 
strains in Tianjin, 66 grouped in one cluster, and the other seven grouped in another cluster, 
with estimated pairwise nucleotide sequence identities of 92.1–100 % and 94.2–100 % 
within the respective clusters. Nucleotide sequence identity between clusters was 85.9–92.1 
% (mean, 89.7 %).
To determine phylogenetic relationships among CV-A6 strains, we constructed an ML tree 
based on complete VP1 nucleotide sequences (915 nucleotides) of Tianjin strains (n = 29) 
and strains from elsewhere in China (n = 21) and other countries (n = 14) during 2008–2013 
(Fig. 3). To facilitate molecular epidemiological descriptions, genogroup designations were 
used to indicate distinct monophyletic clades.
In the ML tree, the prototype strain CV-A6/Gdula and three other strains from China and 
India were distantly related to the Tianjin sequences and separated into distinct clades 
(genogroups A, B, and C). The Tianjin strains and the rest of the reference strains (31/35) 
grouped in another monophyletic clade (genogroup D, 100 % bootstrap support). The 
topology of the tree revealed at least three different clusters of CV-A6 strains within 
genogroup D (indicated as clusters 1, 2, and 3), which were supported by bootstrap values of 
≥84 %. Most Tianjin strains (n = 27) grouped in cluster 1, and the other two Tianjin strains 
grouped in cluster 2 (Fig. 3). All previous CV-A6 strains from China were also grouped in 
clusters 1 (n = 16) and 2 (n = 4), except JQ364886. The Tianjin strains were closely related 
to strains from Fujian, Guangdong, Jiangsu, Henan, and Shandong provinces during 2008–
2013. The prevalent lineages in Guangdong province described previously [10, 13] were 
also grouped in cluster 1, indicating the prevalence of cluster 1 in China. In clusters 1 and 2, 
there were also strains from Japan, Spain, France and Taiwan during 1999–2013, which 
were associated with HFMD, herpangina, or onychomadesis after HFMD [2, 4, 7, 16]. CV-
A6 strains from Spain in 2008 and France in 2010 constituted cluster 3. Genogroups A, B, 
and C contained very few members, which might be due both to a lack of complete VP1 
nucleotide sequence data and limited virus circulation.
We estimated pairwise distances (p-distance) among sequences shown in the phylogenetic 
tree (Fig. 3). Inter-genogroup distances ranged from 12.4 % to 18.4 %. Inter-cluster 
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distances within genogroup D ranged from 8 % to 11 %, whereas pairwise distances within a 
cluster were ≤7 %.
To investigate the evolutionary details, an MCC tree was constructed based on complete 
VP1 nucleotide sequences of Tianjin strains (n = 29) and strains related closely to the 
Tianjin strains in the ML tree (n = 12) (Fig. 4). In the topology of the MCC tree (Fig. 4), the 
strains (n = 41) split into two main clusters (clusters 1 and 2), in agreement with the 
topologies of the ML (Fig. 3) and neighbor-joining trees (not shown). Each cluster further 
split into several individual lineages. Prevalent Tianjin lineages were grouped in cluster 1 
(Fig. 3 and 4). In cluster 1, the lineages from Tianjin showed a close relationship to strains 
isolated during 2012–2013 from Fujian, Jiangsu, and Guangdong provinces, located in 
eastern or southern China (Fig. 4), indicating that the CV-A6 lineages causing the outbreak 
in this study were co-circulating widely around eastern and southern China rather than being 
localized to Tianjin. CV-A6 strains from other provinces were interspersed on the coalescent 
path of Tianjin strains in the MCC tree, and infections with the most recent common 
ancestor of strains in other provinces and strains in Tianjin were estimated to have occurred 
between 2011 and 2012 (Fig. 4). The MCMC results suggested that one to two years before 
the outbreak in 2013, CV-A6 of cluster 1 had been transmitted actively and widely in these 
areas. In general, the confidence intervals for time estimates were reasonable (as shown in 
node bars in Figure 4), except in nodes with posterior probabilities <0.75, for which 
confidence intervals were not determined. Estimates of the time to the most recent common 
ancestor of members of cluster 1 suggested that these viruses circulated endemically within 
the region for at least 6 years (95 % HPD: 3–9 years). Clusters 1 and 2 share a deep node 
with an estimated time to the most recent common ancestor of 19 years (95 % HPD: 13–26 
years). The estimated mean evolutionary rate from the MCC tree was 4.10 × 10−3 
substitutions per site per year (95 % HPD: 2.46 × 10−3 – 5.73 × 10−3), which is consistent 
with the evolutionary rate estimated from expanded CV-A6 surveys (>300 VP1 sequences) 
and rates estimated previously [10].
Discussion
HFMD is a common infectious childhood disease that is associated with EV infections. 
Numerous outbreaks have been reported in the Western Pacific Region [1, 11, 12, 22]. In 
Mainland China, HFMD was classified as a class “C” notifiable disease in 2008. Enhanced 
surveillance demonstrated persistent HFMD outbreaks throughout China during the last 6 
years, with nine million cases reported. Based on nationwide data, EV-A71 and CV-A16 
were the predominant pathogens during 2009–2012 [29]. However, a remarkable increase in 
the proportion of CV-A6 was detected in Shenzhen city since September, 2012 [10], 
followed by emergence of CV-A6 outbreaks reported in both southern and northeastern 
China in 2013 [9, 13]. In this study, surveillance for HFMD in Tianjin revealed an emerging 
outbreak of CV-A6 in 2013 in northern China. Although CV-A6 has been associated with 
several outbreaks of HFMD in Finland, Spain, Japan, Thailand, the United States, and 
Taiwan since 2008 [7, 8, 13, 15, 16, 21, 27], it was detected only sporadically in Mainland 
China before 2013 [14, 25, 30].
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In previous studies on CV-A6, molecular epidemiological analyses were all based on partial 
VP1 nucleotide sequences [10, 16, 27]. In this study, we analyzed complete VP1 nucleotide 
sequences of CV-A6 strains from Tianjin as well as those obtained in other surveys in Asia 
and Europe. The dataset used for analysis was limited due to low accessibility of complete 
VP1 sequences and incomplete surveillance of CV-A6. Nevertheless, this study revealed 
that the genetic group encompassing Tianjin sequences was the most prevalent worldwide, 
was associated with several global outbreaks since 2008 [2, 4, 7, 16], and included most of 
the sequences from Mainland China. CV-A6 was associated with onychomadesis, 
herpangina, typical and atypical HFMD during previous outbreaks [7, 8, 15, 16, 27]. 
Surveillance programs for HFMD and acute flaccid paralysis (AFP; to detect poliovirus) are 
the only nationwide surveillance programs for EV in China. It is uncertain whether CV-A6 
also causes other diseases in China.
In our study, multiple lineages of CV-A6 from two distinct genetic clusters (clusters 1 and 
2) were found to be co-circulating independently in Tianjin (Fig. 3 and 4). Cluster 1 
encompassed not only the major lineages from the outbreak in Tianjin but also major 
lineages from an outbreak in Guangdong [10], indicating the prevalence of cluster 1 in 
China. Because serotyping for other EV was not required for the surveillance system in 
China, national data on CV-A6 were not available. However, the analyses revealed the 
widespread circulation of CV-A6 in several regions of China. Moreover, a remarkable 
increase in the prevalence of other EVs (≥50 %) was identified in 15 provinces in 2013 
according to unpublished surveillance data on HFMD. The activity of other EVs in China 
requires further attention.
HFMD primarily affects young children, for whom the age-specific incidence can be quite 
high [29]. In Tianjin, the age group with the highest incidence of HFMD varied from year to 
year, but this disease was commonly found in children aged between 1 and 3 years (Fig. 2). 
However, in 2013, when CV-A6 emerged, the highest incidence was seen in 1-year-old 
children, as was also observed in another outbreak of CV-A6 [15]. It is possible that CV-A6 
circulated for several years in Tianjin before 2013 and that the older age group might have 
been immunized due to natural infection with CV-A6 during previous years. Additional 
studies of CV-A6 seroprevalence might be necessary for further clarification. In 2013, the 
rate of severe cases was much lower (295 per 100,000) than that during the previous three 
years (987 to 2200 per 100,000), when the proportion of EV-A71 was much higher (Table 
1), suggesting that the virulence of CV-A6 is lower than that of EV-A71. The reasons for 
this are unknown.
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Temporal distribution of reported cases of HFMD and cases of EV detected in Tianjin, 
2008–2013. (A) Weekly distribution of reported cases and cases with specimens collected 
for EV detection, indicated on the left and right axis, respectively. (B) Monthly distribution 
of severe and fatal cases
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Incidence of HFMD in Tianjin in 2008–2013 according to age
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Maximum-likelihood tree based on complete VP1 nucleotide sequences (915 nucleotides) of 
CV-A6 strains from this study and references from GenBank. Tianjin sequences are 
indicated by arrows. The other sequences are indicated by GenBank accession number, 
country and year (where available). Chinese provinces: FJ, Fujian; GD, Guangdong; HeN, 
Henan; JS, Jiangsu; SD, Shandong
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MCC tree of complete VP1 nucleotide sequences (915 nucleotides) of CV-A6 strains 
representing D1 and D2 clusters. The scale is in units of evolutionary time in years, using 
the relaxed clock model [5], with an estimated mean rate of 4.49 × 10−3 substitutions/site/
year. The time period from year 2012 to 2013 is indicated by a gray rectangle
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Table 1
Annual number and incidence of HFMD cases reported in Tianjin, 2008–2013
Year No. of cases reported Incidence (per 100,000) No. of severe cases No. of fatal cases
2008     7839 70.3047   44   1
2009   10125 86.0969     9   0
2010   28178 229.4325   62   5
2011   22280 172.2006   22   5
2012   20705 152.8517   38   3
2013   13578 96.0832     4   2
Total 102705 – 179 16
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